Predicting VAP mortality

In this observational analysis of 178 patients with VAP, researchers determined the predictive value of a simple tool (IBMP-10*) in determining in-hospital mortality. The simple 0-5 point score was more predictive than APACHE in predicting mortality with an AUC of .824 (abstract). Risk of death was 2% (for score of zero) and 67% (for score of 4). If validated in other studies, this will be a quick and easy tool for determining mortality risk in VAP patients.

[*I=Immunodeficiency, B=BP<90/60, M=Multi-lobar, P=Plt<100K, 10=hospital duration >10 days prior to VAP]

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment